Phytocannabinoids For Diabetes Treatment? GrowLab Pharmaceuticals' Clinical Trials Show Promising Results
GrowLab Pharmaceuticals PLC recorded 96% clinical diabetes remission following independent clinical trials of its phytocannabinoids based therapeutic Comacadine curated and synthesized from its proprietary DNA-specific strains of medical cannab
